Iorgulescu, J. B., Harary, M., Zogg, C. K., Ligon, K. L., Reardon, D. A., Hodi, F. S., . . . Smith, T. R. (2018). Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort. Cancer Immunol Res.

Iorgulescu, J. Bryan, Maya Harary, Cheryl K. Zogg, Keith L. Ligon, David A. Reardon, F. Stephen Hodi, Ayal A. Aizer, and Timothy R. Smith. "Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results From a National Cohort." Cancer Immunol Res 2018.

Iorgulescu, J. Bryan, et al. "Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results From a National Cohort." Cancer Immunol Res 2018.